» Articles » PMID: 24113258

Non-neuronal Cell Responses Differ Between Normal and Down Syndrome Developing Brains

Overview
Specialty Neurology
Date 2013 Oct 12
PMID 24113258
Citations 22
Authors
Affiliations
Soon will be listed here.
Abstract

Down syndrome (DS), the most common genetic cause of mental retardation, is characterized by reduced number of neurons and delayed myelination. Though non-neuronal cells in the brain are vital for the development, survival, and function of neurons, there is a paucity of comparative studies of normal development and DS, in particular in the temporal lobe, a region of interest for cognitive decline. We evaluated immunoreactivity for CD68 (macrophage), HLA-DR (microglia), Olig2 and TPPP/p25 (oligodendroglia), and GFAP (astroglia) in the germinal matrix (GM), temporal lobe white matter (TeWM) and hippocampus from 14 weeks of gestations to newborn in 28 DS patients and 30 age-matched controls. The rate of increase of CD68 positive cells in the GM, CA1 hippocampal subregion and subiculum was significantly higher in DS. The density of Olig2 positive cells in the GM was lower in DS brains at early stages, then showed a transient increase contrasting controls. Olig2 expression increased more in the TeWM in DS, suggesting an altered pattern of oligodendrocyte progenitor generation. GFAP-immunoreactivity in DS was significantly lower in the middle pregnancy period in the TeWM and did not increase between early and middle periods in the GM compared to controls, likely reflecting a defect in astrocyte production. The altered expression of non-neuronal cell markers during normal development and DS may play a role in, or reflect, defective neurogenesis, leading to reduced number of neurons and delayed myelination in the developing DS brain. This has implications for the understanding of the mental retardation in DS patients.

Citing Articles

Astrocytic Alterations and Dysfunction in Down Syndrome: Focus on Neurogenesis, Synaptogenesis, and Neural Circuits Formation.

Uguagliati B, Grilli M Cells. 2025; 13(24.

PMID: 39768129 PMC: 11674571. DOI: 10.3390/cells13242037.


Bta-miR-665 improves bovine blastocyst development through its influence on microtubule dynamics and apoptosis.

Guan X, Fan Y, Six R, Benedetti C, Raes A, Fernandez Montoro A Front Genet. 2024; 15:1437695.

PMID: 39479397 PMC: 11521815. DOI: 10.3389/fgene.2024.1437695.


The role of Down syndrome cell adhesion molecule in Down syndrome.

Hergenreder T, Yang T, Ye B Med Rev (2021). 2024; 4(1):31-41.

PMID: 38515781 PMC: 10954295. DOI: 10.1515/mr-2023-0056.


Distinct Molecular Signatures of Amyloid-Beta and Tau in Alzheimer's Disease Associated with Down Syndrome.

Ichimata S, Martinez-Valbuena I, Lee S, Li J, Karakani A, Kovacs G Int J Mol Sci. 2023; 24(14).

PMID: 37511361 PMC: 10380583. DOI: 10.3390/ijms241411596.


From neurodevelopment to neurodegeneration: utilizing human stem cell models to gain insight into Down syndrome.

Watson L, Meharena H Front Genet. 2023; 14:1198129.

PMID: 37323671 PMC: 10267712. DOI: 10.3389/fgene.2023.1198129.